Author:
Tanaka Yoshiaki,Masaki Takanori,Uojima Haruki,Ohtake Takayasu,Fujikawa Tomoaki,Yamanouchi Yasuhiro,Wada Naohisa,Kubota Kousuke,Hidaka Hisashi,Nakazawa Takahide,Shibuya Akitaka,Aoyama Togo,Sung Ji Hyun,Kako Makoto,Kobayashi Shuzo,Takeuchi Yasuo,Koizumi Wasaburo
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Urology,Nephrology
Reference24 articles.
1. Toyoda H, Atsukawa M, Takaguchi K, Senoh T, Michitaka K, Hiraoka A, et al. Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in Japan. J Gastroenterol. 2018.
https://doi.org/10.1007/s00535-018-1473-z
.
2. Okubo T, Atsukawa M, Tsubota A, Toyoda H, Shimada N, Abe H, et al. Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment. Hepatol Int. 2018;12:133–42.
3. Pol S, Jadoul M, Vallet-Pichard A. An update on the management of hepatitis C virus-infected patients with stage 4-5 chronic kidney disease while awaiting the revised KDIGO guidelines. Nephrol Dial Transplant. 2017;32:32–5.
4. Arai T, Atsukawa M, Tsubota A, Ikegami T, Shimada N, Kato K, et al. Efficacy and safety of ombitasvir/paritaprevir/ritonavir combination therapy for genotype 1b chronic hepatitis C patients complicated with chronic kidney disease. Hepatol Res. 2018;48:549–55.
5. Alseiari M, Meyer KB, Wong JB. Evidence underlying KDIGO (kidney disease: improving global outcomes) guideline recommendations: a systematic review. Am J Kidney Dis. 2016;67:417–22.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献